Novel Agents Improving Outcomes for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm - Episode 1

Diagnosing Blastic Plasmacytoid Dendritic Cell Neoplasm

Sangeetha Venugopal, MD, MS, provides an overview of how patients with blastic plasmacytoid dendritic cell neoplasms (BPDCN) are diagnosed.

Now Viewing
EP. 1: Diagnosing Blastic Plasmacytoid Dendritic Cell Neoplasm
EP. 2: BPDCN: A Multidisciplinary Approach to Diagnosis and Treatment
EP. 3: Pivekimab Sunirine: A Novel CD123 ADC Showing Promise for BPDCN
EP. 4: Advances in Diagnosis and Targeted Therapies for BPDCN from an Expert Dermatopathologist
EP. 5: Emerging CD123-Targeted Therapies for BPDCN: Pivotal Trial Insights and Future Potential